Showing 861 - 880 results of 103,198 for search '(( 50 ((nn decrease) OR (mean decrease)) ) OR ( 5 ((c decrease) OR (a decrease)) ))', query time: 1.74s Refine Results
  1. 861

    Decreased immunofluorescence during multiplex staining. by Sandrine Prost (38667)

    Published 2016
    “…<p>Serial sections were stained with 1 to 5 different markers (Marker 1, MHCII Qdot 705Vivid; Marker 2, HO1 Qdot 605Vivid; Marker 3, CD163 Qdot 565; Marker 4, CD206 Qdot 655Vivid; Marker 5, CD68 streptavidin Qdot 525). …”
  2. 862
  3. 863

    AICD transgenic mice show decreased cell proliferation in the SGZ of hippocampus. by Kaushik Ghosal (244754)

    Published 2010
    “…<p>Representative images of BrdU immunostaining in the subgranular zone (SGZ) of the dentate gyrus performed on 1.5-mont-old (<b>A</b>) 3-month-old (<b>C</b>) and 12-month old (<b>D</b>) wild-type and FeCγ25 animals one day after the final BrdU injection (100 mg/kg). …”
  4. 864
  5. 865
  6. 866
  7. 867
  8. 868
  9. 869

    ApoER2 expression increases Aβ production while decreasing Amyloid Precursor Protein (APP) endocytosis: Possible role in the partitioning of APP into lipid rafts and in the regulat... by Rodrigo A Fuentealba (77901)

    Published 2011
    “…</p><p></p>hich is based on the secretase-dependent cleavage of a γ-secretase-specific substrate conjugated with a fluorescent molecule. Data represent mean ± S.E.M of three experiments in duplicated, presented as fold values of the basal activity. * P < 0.05, ** P < 0.01. (), 50 μg of protein/lane were subjected to 12% SDS-PAGE and endogenous PS1 levels were determined by Western blot. …”
  10. 870
  11. 871
  12. 872

    GSK343 decreased tumor stemness. by Laura V. Bownes (10276762)

    Published 2021
    “…(C) COA6 cells were treated with GSK343 (0, 5 μM) for 72 hours. qPCR demonstrated a significant decrease in mRNA abundance of known stemness markers Oct4, Nanog, and Sox2 following GSK343 treatment compared to untreated cells. …”
  13. 873
  14. 874
  15. 875
  16. 876
  17. 877
  18. 878
  19. 879

    A functional PSA mimetic peptide (fPSA) prevents glutamate-induced MAP-2 decrease and concomitant changes in SYN and NCAM synaptic patterns and levels. by María Fernanda Podestá (639243)

    Published 2014
    “…(B) Quantification of MAP-2 immunoreactive area showed decreased levels 6 h after glutamate exposure; this decrease was prevented by fPSA. …”
  20. 880